Raymond James & Associates reduced its stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 4.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 874,410 shares of the business services provider's stock after selling 40,043 shares during the quarter. Raymond James & Associates owned approximately 0.95% of Stericycle worth $43,336,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in the stock. Quarry LP acquired a new stake in shares of Stericycle in the first quarter worth $30,000. Ancora Advisors LLC bought a new stake in Stericycle in the 1st quarter valued at $34,000. International Assets Investment Management LLC acquired a new stake in shares of Stericycle in the 3rd quarter valued at $36,000. First Capital Advisors Group LLC. acquired a new stake in shares of Stericycle in the 2nd quarter valued at $36,000. Finally, Point72 Middle East FZE acquired a new stake in shares of Stericycle in the 4th quarter valued at $39,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.
Stericycle Trading Down 0.7 %
Stericycle stock traded down $0.35 during trading hours on Friday, reaching $52.75. 315,375 shares of the company's stock traded hands, compared to its average volume of 569,456. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The firm has a market capitalization of $4.88 billion, a price-to-earnings ratio of -219.79, a PEG ratio of 2.87 and a beta of 1.11. The firm's 50 day moving average is $50.90 and its 200-day moving average is $47.40.
Stericycle (NASDAQ:SRCL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.07. The company had revenue of $652.00 million during the quarter, compared to analysts' expectations of $657.99 million. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. Stericycle's revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.60 EPS. On average, analysts predict that Stericycle, Inc. will post 2.31 earnings per share for the current year.
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. StockNews.com downgraded shares of Stericycle from a "buy" rating to a "hold" rating in a research report on Friday, March 22nd. Stifel Nicolaus upped their price target on shares of Stericycle from $70.00 to $75.00 and gave the stock a "buy" rating in a research report on Thursday, February 29th. Truist Financial upped their price target on shares of Stericycle from $50.00 to $57.00 and gave the stock a "hold" rating in a research report on Thursday, February 29th. Royal Bank of Canada reiterated an "outperform" rating and set a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. Finally, Wells Fargo & Company upped their price target on shares of Stericycle from $40.00 to $48.00 and gave the stock an "underweight" rating in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $62.25.
Get Our Latest Analysis on Stericycle
Stericycle Company Profile
(
Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
